the TRIUMPH thing finally clicked for me and I want to write it down
The title is the argument: the TRIUMPH thing finally clicked for me and I want to write it down. Here is the rest of it. Independent purity testing on this compound is thin compared with the older molecules, simply because fewer members have paid for it. Fewer results means wider uncertainty, not a verdict. Nothing…
nothing here is available as a prescription product, so read every thread with that in mind
The thing that surprised me was how much of the discussion here is inference rather than measurement.
[removed by moderator]
the energy-expenditure story is mechanistically interesting and clinically unproven
Disagree. "More receptors means more effect" is not how any of this works and the trial data does not support the linear story.
the phase 2 numbers were striking and they were also 48 weeks in a small population
Read the phase 2 paper twice before ordering anything. Recommend that to anyone in this board: the error bars are the interesting part.